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Rebuilding of brain structures and nervous circuitries with grafting of fetal tissue is 
currently being explored as a strategy to repair the damaged nervous system (Handb 
Clin Neurol 2009).
Experimental studies demonstrated that transplanted neuroblasts can survive and 
proliferate in the host. Migration of primary or expanded neural precursors following 
transplantation has also been well documented. Cell migration plays a pivotal role in 
the organogenesis and contributes to multiple processes in adulthood, such as tissue 
repair and immune response. Migrating neuroblasts are capable of anatomically re-es-
tablishing damaged neural circuitries in the adult animal brain. These results suggest 
that there might also be a real potential for neurotransplantation in humans in order to 
promote reconstruction after brain injury. The challenge of such an approach is that the 
primordium recapitulates its ontogenesis in the host, being deprived of the fetal brain 
environmental cues, while it is subject to extrinsic cues coming from the diseased adult 
brain. In animals, recapitulation of normal development was achieved “simply“ by im-
planting fetal neurons.
Striatal fetal grafting as a strategy of cell replacement has been extensively inves-
tigated in Huntington’s disease (HD) animal models. There is evidence that primary 
grafts of human fetal striatal tissue contain proliferative cells capable of migrating, dif-
ferentiating and establishing robust graft-host interconnectivity, significantly recovering 
lesion-induced damage, without graft overgrowth or neoplastic proliferation (Lancet 
Neurol 2006).
Based on these studies and the fact that current therapies do not prevent the unre-
lenting clinical course of HD, a clinical trial of human fetal striatal tissue transplantation 
for the treatment of HD has been initiated at the University of Florence. Fifteen HD pa-
tients underwent bilateral transplantation. The current report provides the first “in vivo“ 
evidence that unmanipulated grafted neural precursors from human striatal anlagen 
developed within the diseased striatum of HD patients and moved into the adult brain, 
reaching short- and long-distance appropriate anatomical targets. The anlagen develop-
ment resulted in the building of metabolically active new nervous structures displaying 
striatal-like imaging features (Exp Neurol 2008, 2010). These events were accompanied 
by beneficial effects on the disease clinical course without negative outcomes, such as 
grafted tissue overgrowth or cyst formation.
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